Tenet Healthcare (THC) Tops Q4 EPS by 15c, Offers Outlook

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $1.40, $0.15 better than the analyst estimate of $1.25. Revenue for the quarter came in at $4.98 billion versus the consensus estimate of $4.87 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2018 EPS of $0.73-$1.07, versus the consensus of $1.02. Tenet Healthcare sees Q1 2018 revenue of $1.79-18.3 billion, versus the consensus of $18.08 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• BMO Capital Starts Tenet Healthcare (THC) at Market Perform
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Tenet Healthcare issues $2B in senior notes to refinance debt